Ryan Haumschild
Director of Pharmacy Services
Emory Healthcare and Winship Cancer Institute, Atlanta, USA
Ryan Haumschild PharmD, MS, MBA is an experienced director of pharmacy at Emory Healthcare and Winship Cancer Institute overseeing profit & loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use across one of the nation’s largest academic integrated delivery networks and Georgia’s only NCI-Designated Comprehensive Cancer Center.
Ryan provides strategic direction within oncology and non-oncology disease states, infusion and specialty pharmacy services, and the expansion of clinical services through treatment pathway development.
He currently serves as an Editorial Board Member at the American Journal of Managed Care® (AJMC®), Board member for both the Institute of Safe Medication Practices (ISMP) and Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.
Ryan Haumschild PharmD, MS, MBA is an experienced director of pharmacy at Emory Healthcare and Winship Cancer Institute overseeing profit & loss responsibility, pharmacy operations, clinical services, formulary management, payer and health plan contracting, and medication use across one of the nation’s largest academic integrated delivery networks and Georgia’s only NCI-Designated Comprehensive Cancer Center.
Ryan provides strategic direction within oncology and non-oncology disease states, infusion and specialty pharmacy services, and the expansion of clinical services through treatment pathway development.
He currently serves as an Editorial Board Member at the American Journal of Managed Care® (AJMC®), Board member for both the Institute of Safe Medication Practices (ISMP) and Center for Biosimilars, and was recently recognized as 40 under 40 by three separate organizations: University of Florida, Atlanta Business Chronicle, and Association for Value-Based Cancer Care.